MGH Neurology clinicians, researchers, and staff at the 2019 McCourt Foundation’s Boston Waterfront 5K, an effort to fundraise for neurology research.
Shibani Mukerji, MD, PhD
Dr. Shibani Mukerji is the Associate Director of the Neuroinfectious Diseases Unit of the Division of Neuroimmunology and Neuroinfectious Diseases at Mass General and Assistant Professor of Neurology at Harvard Medical School. She is an MD and PhD graduate of Case Western Reserve School of Medicine, and completed a postdoctoral fellowship in Dr. Dana Gabuzda lab at the Dana Farber Cancer Center. Dr. Mukerji received specialized clinical training in the neurological management of infectious diseases from the Mass General Brigham/Harvard Medical School residency and fellowship programs and sees patients with HIV infection in the MGH Neurology Department and the Division of Infectious Diseases. She is a co-investigator on the Phase II clinical trial “A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV” and PI of the MGH Prospective Encephalitis and Meningitis Study (PEMS), a clinical research platform that combines patient data with biofluids to improve detection of acute neurological infections. Dr. Mukerji grew up in Phoenix and enjoys spending time biking and traveling with her husband and daughter.
Douglas Wilcox, MD, PhD
Doug works in the Mukerji Lab as a Resident Physician in the Harvard BWH-MGH Neurology Program. He completed both his MD and PhD from Northwestern University, where he worked with Dr. Richard Longnecker on the pathogenesis of Herpes Simplex Virus Encephalitis.
Doug also works with Dr. Chenghua Gu at Harvard Medical School on the immune response to pathogens at the blood-brain barrier. In the Mukerji lab, his focus is on the pathogenesis of acute viral encephalitis, including Eastern Equine Encephalitis (EEE) and Herpes Simplex Encephalitis (HSE). Doug grew up in Durham, New Hampshire and enjoys hiking and traveling.
Clinical Research Coordinator
Sarah joined the Mukerji Lab as a clinical research coordinator in July 2019 after graduating from Lafayette College with a BS in Neuroscience. During her undergraduate career, Sarah completed research projects developing novel therapeutics to combat antibiotic-resistant bacterial pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa. In the Lab, Sarah works on various projects looking at the neurological impact of neuroinvasive infectious diseases. She is the lead coordinator for the Prospective Encephalitis and Meningitis Study (PEMS) with the goal of pathogen and autoantibody discovery in suspected infectious and autoimmune disease of the central nervous system. Sarah is from Pelham Manor, New York and hopes to pursue a career in medicine. During her free time, she enjoys traveling, playing soccer, and trying new restaurants.
Clinical Research Coordinator
Kiana joined the Mukerji Lab as a clinical research coordinator in June 2018 after finishing her BS degree in Neuroscience and Studio Art at Bates College. She is from Mililani, Hawaii and previously did neuro-HIV research with the Hawaii Center for AIDS. She is the lead coordinator for the neurological sub-study of the Phase II clinical trial investigating the impact of gut permeability on blood vessels of the heart in people with HIV. She is excited to start medical school in the summer of 2020. In her free time, she enjoys reading, drawing, and going to art museums.
Your donations help to elicit the greatest potential from the department’s superb team and fuel the research that will result in better treatment and ultimately, cures for neurological disorders.